Completed NA INTERVENTIONAL 2-arm NCT01310270

The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation (OMEGA-PAD)

Sponsor: University of California, San Francisco

Interventions Omega 3 Fatty Acid Pro-Omega

Updated 9 times since 2017 Last updated: Oct 28, 2021 Started: Apr 30, 2011 Primary completion: Dec 31, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01310270, this NA trial focuses on Peripheral Arterial Disease and remains completed. Sponsored by University of California, San Francisco, it has been updated 9 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2021 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE2 → NA
Jan 2021 — Dec 2021 [monthly]

Unknown Status PHASE2
Feb 2020 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status

▶ Show 4 earlier versions

Jun 2018 — Feb 2020 [monthly]

Recruiting PHASE2
Jan 2018 — Jun 2018 [monthly]

Recruiting PHASE2

Status: Completed → Recruiting
Feb 2017 — Jan 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of California, San Francisco

Data source: University of California, San Francisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Francisco, United States